Clinical efficacy of cat or dog allergen immunotherapy. A real-life study
Background: Few studies have demonstrated the efficacy of the subcutaneous immunotherapy (SCIT) in patients with cat and dog allergy . Methods: Sixty-six allergic patients to cat and dog were selected from a previous study, which received SCIT Alutard® SQ (Alk-abelló, Spain) with cat or dog extract...
Main Authors: | Silvia Uriarte, Joaquín Sastre |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2018-06-01
|
Series: | Revista Alergia México |
Subjects: | |
Online Access: | http://revistaalergia.mx/ojs/index.php/ram/article/view/422 |
Similar Items
-
Safety of an ultra-rush subcutaneous immunotherapy using an infusion pump in real-life
by: Silvia Uriarte, et al.
Published: (2018-06-01) -
The clinical efficacy of allergen-specific immunotherapy with water-salt extracts and adjuvant allergens for atopic asthma with household sensitization
by: D V Ushakova, et al.
Published: (2017-12-01) -
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic
by: Ilkay Koca Kalkan, et al.
Published: (2021-07-01) -
Grand Challenges in Allergen Immunotherapy
by: Linda Cox
Published: (2021-08-01) -
Quality of life of patients undergoing specific allergen immunotherapy in allergic rhinitis
by: Magdalena Brodowicz-Król, et al.
Published: (2020-12-01)